An Ohio physician who owned a Dayton-area medical practice
pleaded guilty today for illegally distributing opioids.
Assistant Attorney General Brian A. Benczkowski of the Justice
Department’s Criminal Division, U.S. Attorney David DeVillers of the Southern
District of Ohio, Special Agent in Charge Keith Martin of the Drug Enforcement
Administration’s (DEA) Detroit Division, Special Agent in Charge Lamont Pugh
III of the U.S. Department of Health and Human Services Office of Inspector
General’s (HHS-OIG) Chicago Regional Office and Special Agent in Charge William
C. Hoffman of the FBI’s Cincinnati Field Office made the announcement.
Morris Brown, M.D. 75, of Dayton, pleaded guilty to one
count of unlawful distribution of controlled substances before U.S. District
Judge Walter Rice of the Southern District of Ohio. Brown is scheduled to be
sentenced by Judge Rice on May 8.
As part of his guilty plea, Brown admitted that he prescribed
controlled substances to patients in amounts and for lengths of time that were
outside the scope of legitimate medical practice. Brown also admitted that he routinely
prescribed controlled substances to patients even though various “red flags” suggested
that he should stop writing those prescriptions, change the prescriptions
and/or counsel patients accordingly.
Further, Brown admitted that he prescribed dangerous combinations of
drugs known to heighten the risk of overdose and death.
Brown owned the building in which his practice operated, and
leased space in the building to a pharmacy named Dayton Pharmacy through which
the vast majority of his prescriptions were filled. Brown admitted to distributing approximately
73.5 kilograms of opioids by converted drug weight.
Brown no longer maintains a DEA registration.
Brown was charged along with Ismail Abuhanieh, 50, of
Phoenix, Arizona; Mahmoud Elmiari, 44, of Bellbrook, Ohio; Yohannes Tinsae, 48,
of Beavercreek, Ohio; and Mahmoud Rifai, 50, of Detroit, Michigan in April
2019. All four of Brown’s co-defendants
were charged for their roles in agreeing to obtain controlled substances for
Dayton Pharmacy by fraud or misrepresentation.
Elmiari and Tinsae have entered guilty pleas and are scheduled for
sentencing on May 13, 2020. Abuhanieh is
scheduled for a change of plea on March 10, 2020. Rifai is the subject of an active arrest
warrant.
All defendants are presumed innocent until proven guilty
beyond a reasonable doubt in a court of law.
The DEA, FBI, HHS-OIG, Ohio Attorney General’s Office, Ohio
Bureau of Worker’s Compensation and Ohio Board of Pharmacy investigated the
case. Trial Attorneys Chris Jason, Tom
Tynan and Leslie Garthwaive of the Criminal Division’s Fraud Section are
prosecuting the case.
The Fraud Section leads the Appalachian Regional
Prescription Opioid (ARPO) Strike Force.
Since its inception in October 2018, the ARPO Strike Force, which
operates in 10 districts, has charged more than 70 defendants who are
collectively responsible for distributing more than 40 million pills. The Health Care Fraud Unit, in general,
maintains 15 strike forces operating in 24 districts, and has charged nearly
4,200 defendants who have collectively
billed the Medicare program for more than $15 billion. In addition, the HHS Centers for Medicare
& Medicaid Services, working in conjunction with HHS-OIG, are taking steps
to increase accountability and decrease the presence of fraudulent providers.
Individuals who believe that they may be a victim in this
case should visit the Fraud Section’s Victim Witness website for more
information.
No comments:
Post a Comment